How we build documents that withstand investor scrutiny.
Investor-grade is a quality bar, not a marketing claim. These pages document the methodology behind each category, what we do, what we don't, and how the work is auditable. Read them before you buy.
Five-stage methodology: scope, sizing, competitive, customer evidence, synthesis. Sources we use, what we cite.
14-section structure investors expect. Financial modeling depth. Competitive analysis. Executive summary as the most important page.
Four-question framework: market, financial, operational, risk. When we give a no-go recommendation.
12-section structure investors expect. Design philosophy. What we won't do (heavy animations, stock photos, clip-art icons).
Five things we do across every category.
Cite every claim.
Every number traces to a source. Every assumption is disclosed. We don't hide methodology; we publish it. Investors who audit our work can follow the trail.
Disclose conservative bias.
We default to base-case conservative. When we use bull-case assumptions, we name them. When we use industry benchmarks instead of your unit economics, we say so. Hidden optimism is what gets plans rejected.
Name competitors. All of them.
“We have no competitors” is the phrase that kills more rounds than any other. Five to seven named competitors per study. Funded competitors get the deeper teardown.
Surface risks. Don't hide them.
Top 10 risks ranked by likelihood × impact. Mitigation for each. Investors and lenders both prefer this. Risk acknowledgment is sophistication; risk avoidance is naiveté.
Refuse what we can't deliver.
If your industry has insufficient publicly available data, we'll tell you within 4 hours of intake. If your scope doesn't fit a productized SKU, we'll refer you to bespoke advisory.